PeptiDex research reference visual for MIC Blend (Lipo-C + B12)
Research Solutions & AdjunctsBlend / Stack

MIC Blend (Lipo-C + B12)

Lipotropic research solution

A research-supplier adjunct blend combining lipotropic compounds with methylcobalamin, referenced in metabolic-research contexts.

Blend
For research and educational purposes only. This page is a factual research reference, not medical advice. Any dosing figures shown are amounts reported in the research literature, provided for educational context — not instructions or recommendations for human use.

Overview

MIC is a lipotropic blend named for its three core components: Methionine, Inositol, and Choline, frequently formulated with added Vitamin B12. It is a compounded wellness formulation, not a single molecule or a peptide.

At a glance

ClassLipotropic research solution
CategoryResearch Solutions & Adjuncts
Typical formSolution / liquid
Use designationResearch / in-vitro only
Regulatory statusA compounded lipotropic blend used in wellness settings; not FDA-approved and composition varies by source. No efficacy claims implied. Educational information only, not medical advice.

What MIC Blend (Lipo-C + B12) does

MIC Blend is a lipotropic injectable built on the same three-nutrient core as Lipo-C - Methionine, Inositol, and Choline (hence 'MIC') - typically combined with vitamin B12 (methylcobalamin). It is not a peptide or drug but a compounded cofactor mixture used as a metabolic adjunct in weight-management and body-composition research contexts, where the components' actions in fat handling and one-carbon (methyl-group) metabolism are meant to complement one another.

The three MIC components map onto liver fat metabolism: choline is essential for making phosphatidylcholine and thus for exporting triglycerides from the liver as VLDL; methionine is a sulfur amino acid and methyl donor (through SAMe) that, among other things, supports choline and phosphatidylcholine synthesis; and inositol contributes to lipid and insulin-related signaling. Adding B12 (methylcobalamin) is intended to support the one-carbon/methylation cycle - B12 and folate regenerate methionine from homocysteine, keeping methyl-donor supply topped up - and B12 is also included for general energy metabolism and its role in red-cell and nerve function.

Mechanistically the rationale is coherent: methyl-donor availability (methionine, B12) and fat-export capacity (choline) are genuinely linked in hepatic metabolism. But as with Lipo-C, robust human clinical data showing that MIC/B12 injections drive fat loss or improve body composition beyond diet and exercise are lacking. It is accurately described as a nutrient-cofactor blend supporting fat and methyl-group metabolism, not a validated fat-loss therapy.

Effects reported in research

  • Provides choline for phosphatidylcholine synthesis and hepatic triglyceride export as VLDL (established biochemistry).
  • Supplies methionine as a SAMe-derived methyl donor supporting transmethylation, including choline/phosphatidylcholine synthesis (established biochemistry).
  • Delivers inositol for inositol-phospholipid-mediated lipid and insulin signaling (established biochemistry).
  • Adds vitamin B12 (methylcobalamin), which with folate regenerates methionine from homocysteine to sustain the methylation cycle (established biochemistry).
  • Combines fat-export (choline) and methyl-donor (methionine, B12) functions so the components' roles in hepatic fat and one-carbon metabolism complement one another (mechanistic rationale).
  • B12 also supports general energy metabolism and red-cell/nerve function (established physiology).
  • Lacks robust human clinical evidence that the injected blend produces fat loss beyond diet and exercise (evidence caveat).

Effects listed reflect findings reported in the research literature — many in animal or in-vitro models. Listing an effect is not a claim of efficacy or a therapeutic indication in humans.

Mechanism of action

The blend combines methyl-donor and lipid-handling compounds: methionine (an essential sulfur amino acid and methyl donor), inositol (a carbocyclic sugar involved in lipid signaling), and choline (required for phospholipid synthesis and hepatic fat export), often with B12 to support one-carbon metabolism. The proposed rationale is supporting the liver's processing and export of fat. Controlled clinical evidence specifically supporting MIC injections for weight loss is limited.

Mechanistic description reflects published research-literature understanding. Much peptide research is preclinical (in-vitro or animal-model); mechanism in humans may differ and is not established for many compounds.

What it's studied for

Research contexts in which MIC Blend (Lipo-C + B12) appears in the literature. Listing a research area is not a claim of efficacy or a therapeutic indication.

Hepatic fat metabolism and methyl-donor supplyCholine / phospholipid and lipoprotein metabolismOne-carbon (methionine-folate-B12) metabolismWellness/weight-management adjunct use (limited controlled evidence)

Key characteristics

  • A compounded blend (Methionine + Inositol + Choline), NOT a peptide
  • Often formulated with added Vitamin B12
  • Rationale is lipotropic support of hepatic fat handling
  • Closely related to Lipo-C, which may add L-carnitine
  • Used in wellness settings; not an approved pharmaceutical and efficacy evidence is limited

Reported research dosing reference only

Educational reference, not dosing guidance. The figures below summarize amounts reported in published research and research-community protocols, provided for educational and research context only. They are not medical advice, not a recommendation, and not instructions for human use. MIC Blend (Lipo-C + B12) is a research compound.

MIC is a compounded blend without a single standardized formula, so component amounts are examples from typical formulations rather than defined dosing. These are reference figures for research context only.

  • Example compounded formulation (per mL): methionine ~25 mg, inositol ~50 mg, choline chloride ~50 mg, plus cyanocobalamin (B12) ~1 mg

These are reference figures for research context only, not dosing guidance for humans. Concentrations vary between compounding pharmacies.

How it compares

MIC is the core methionine/inositol/choline lipotropic blend; Lipo-C is a related, often broader formulation that may add L-carnitine and/or additional B vitamins.

Blend components

This entry documents a research-supplier blend combining the following. Each component is documented as its own PeptiDex entry where available:

MethionineComponent
InositolComponent
CholineComponent
Vitamin B12 (commonly added)Component

Commonly studied alongside

Compounds frequently researched together with MIC Blend (Lipo-C + B12) in the literature. Cross-referenced for research context — not a usage or combination recommendation.

Handling & Stability

Liquid research solutions are typically stored cold and used within supplier-stated shelf life.

  • Avoid repeated freeze-thaw cycles
  • Verify supplier lot and Certificate of Analysis
  • Follow institutional lab-safety protocols

Analytical & COA Concepts

Reputable research suppliers publish a third-party Certificate of Analysis per batch. Key analytical concepts referenced in COAs include:

Category Context

MIC Blend (Lipo-C + B12) sits in the Research Solutions & Adjuncts area of the PeptiDex library.

Research Supplier Listing

Where researchers source MIC Blend (Lipo-C + B12)

For researchers studying MIC Blend (Lipo-C + B12), third-party suppliers such as Practically Natty Peptides offer research-grade material with third-party Certificates of Analysis and US-based shipping.

Explore Research Suppliers →

PeptiDex does not maintain a direct supplier listing for this compound. The link above goes to a third-party research-supplier directory.

Frequently asked questions

What is a MIC blend?

MIC stands for Methionine, Inositol, and Choline - the three lipotropic compounds at the core of the blend, typically combined with vitamin B12. It is a mixture of small-molecule nutrients, not a peptide. It is used in a metabolic/lipotropic research and compounding context.

What does each MIC component do?

Methionine is an essential amino acid that supports the liver's handling of fatty acids; inositol assists in the transport of fat into and out of cells; and choline supports mobilization of fatty acids and helps prevent their deposition in the liver. Together they are described as 'lipotropic' agents, meaning they are theorized to support fat metabolism.

How does a MIC blend differ from Lipo-C?

The MIC blend is the core methionine/inositol/choline formula (commonly with added B12). Lipo-C generally builds on this base by adding L-carnitine and further B-vitamins or cofactors. The two are closely related members of the same lipotropic family, with Lipo-C being the more extended formulation.

Is there strong evidence MIC blends cause weight loss?

No. The individual nutrients are legitimate, but there are no randomized controlled trials demonstrating that MIC injections produce clinically significant weight loss independent of diet and exercise. MIC is best framed as a metabolic-support research solution rather than a proven weight-loss therapy.

Why is B12 usually added to MIC?

Vitamin B12 (cyanocobalamin) is commonly added for general energy and metabolic support and because it is well tolerated in injectable form. Its inclusion is why the blend is often written as 'MIC + B12,' though the exact concentrations vary by compounding source.

Answers are educational summaries of research-literature context and do not constitute medical advice. See the Research Library, COA guide, and Storage & Handling guide for more.

Related compounds in Research Solutions & Adjuncts

Further reading